Home / PPBT : NASDAQ

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does PPBT make money? Does PPBT have pricing power? What's the Earnings Whisper? Will PPBT profit more as the business scales? What is PPBT's management track record? Is PPBT's current price justified?

Purple Biotech Ltd.

$1.72 -$4.88 (-73.94%)

NASDAQ · 11 Sep 2026 20:00 UTC

Previous Close

$1.74

Day Range

$1.62$1.79

Year Range

$1.16$14.1

Market Cap

237.5K

AVG Volume

1.11M

Trailing/Forward PE

-0.01/-

PEG ratio

Dividend Yield

Next Earnings Date

2026-11-13

Primary Exchange

NASDAQ

Revenue (USD)

PPBT Revenue (USD) by year
Period	Revenue (USD)
2025	0
2024	0
2023	0
2022	0
2021	0
2020	1M
2019	1M
2018	1M
2017	100K
2016	0

Net Income (USD)

PPBT Net Income (USD) by year
Period	Net Income (USD)
2025	-26.39M
2024	-7.24M
2023	-19.88M
2022	-21.67M
2021	-18.38M
2020	-28.62M
2019	-5.36M
2018	-5.2M
2017	-12.18M
2016	-12.12M

Operating Income (USD)

PPBT Operating Income (USD) by year
Period	Operating Income (USD)
2025	-27.45M
2024	-11.07M
2023	-22.27M
2022	-15.42M
2021	-17.65M
2020	13.26M
2019	-6.67M
2018	-8.69M
2017	-10.59M
2016	-7.18M

EBITDA (USD)

PPBT EBITDA (USD) by year
Period	EBITDA (USD)
2025	-26.23M
2024	-7.05M
2023	-19.72M
2022	-21.49M
2021	-17.23M
2020	-12.84M
2019	-6.04M
2018	-8.02M
2017	-10.07M
2016	-7.1M

Cash Flows (USD)

PPBT Cash Flows (USD) by year
Period	Cash Flows (USD)
2025	-5.66M
2024	-14.37M
2023	-19.93M
2022	-16.96M
2021	-15.37M
2020	-12.17M
2019	-5.59M
2018	-8.5M
2017	-8.64M
2016	-6.27M

EPS (USD)

PPBT EPS (USD) by year
Period	EPS (USD)
2025	-2.84
2024	-51
2023	-182.2
2022	-240.2
2021	-202.6
2020	-501
2019	-553.4
2018	-843.2
2017	-2640
2016	-3960

Expenses (USD)

PPBT Expenses (USD) by year
Period	Expenses (USD)
2025	6.71M
2024	10.62M
2023	22.08M
2022	22.58M
2021	18.14M
2020	13.22M
2019	6.33M
2018	9.05M
2017	10.19M
2016	7.11M

Cash & Debt (USD)

PPBT Cash & Debt (USD) by year
Period	Cash & Debt (USD)
2025	9.57M
2024	8.52M
2023	15.41M
2022	32.11M
2021	47.2M
2020	57.8M
2019	6.39M
2018	6.68M
2017	3.95M
2016	14.66M

Debt ratios

PPBT Debt ratios by year
Period	Debt ratios
2025	0.13
2024	0.13
2023	0.21
2022	0.55
2021	1.05
2020	1.54
2019	0.2
2018	0.24

Margins

PPBT Margins by year
Period	Margins
2020	100%
2019	100%
2018	100%
2017	100%

Return on Capital

PPBT Return on Capital by year
Period	Return on Capital
2025	-273.18%
2024	-22%
2023	-57.96%
2022	-46.01%
2021	-28.24%
2020	-35.89%
2019	-49.38%
2018	-47.24%
2017	-141.7%
2016	-90.58%

Shares Outstanding

PPBT Shares Outstanding by year
Period	Shares Outstanding
2025	11.91M
2024	205.21K
2023	127.89K
2022	91.95K
2021	101.55K
2020	44.43K
2019	13.92K
2018	8K
2017	5.36K
2016	3.79K

Book Value Per Share (USD)

PPBT Book Value Per Share (USD) by year
Period	Book Value Per Share (USD)
2025	0.81
2024	160.38
2023	268.17
2022	512.23
2021	641.15
2020	1794.84
2019	780.19
2018	1375.16
2017	1602.57
2016	3529.8

Total Assets (USD)

PPBT Total Assets (USD) by year
Period	Total Assets (USD)
2025	17.57M
2024	37.04M
2023	44.3M
2022	54.62M
2021	70.2M
2020	83.8M
2019	14.72M
2018	14.72M
2017	14.18M
2016	14.91M

Employee Count

PPBT Employee Count by year
Period	Employee Count
2025	10
2024	9
2023	20
2022	20
2021	19
2020	13
2019	9
2018	10
2017	9
2016	7

Free Cash Flow Yield

PPBT Free Cash Flow Yield by year
Period	Free Cash Flow Yield
Sep 26	-41.55%
Sep 26	-40.83%
Aug 26	-42.54%
Aug 26	-45.52%
Aug 26	-47.64%
Aug 26	-49.97%
Jul 26	-51.98%
Jul 26	-50.89%
Jul 26	-49.5%
Jul 26	-46.64%
Jul 26	-42.8%
Jun 26	-43.31%
Jun 26	-42.8%
Jun 26	-46.05%
Jun 26	-24.5%
May 26	-24.34%
May 26	-25.27%
May 26	-18.47%
May 26	-11.51%
May 26	-11.31%
Apr 26	-10.47%
Apr 26	-9.76%
Apr 26	-11.51%
Apr 26	-11.56%
Mar 26	-11.85%
Mar 26	-11.94%
Mar 26	-11.59%
Mar 26	-30.32%
Feb 26	-32.79%
Feb 26	-29.28%
Feb 26	-25.03%
Feb 26	-24.08%
Jan 26	-24%
Jan 26	-21.83%
Jan 26	-22.9%
Jan 26	-20.97%
Jan 26	-21.96%
Dec 25	-20.53%
Dec 25	-20.5%
Dec 25	-19.27%
Dec 25	-17.44%
Nov 25	-39.07%
Nov 25	-42.13%
Nov 25	-44.95%
Nov 25	-39.45%
Oct 25	-41.11%
Oct 25	-54.7%
Oct 25	-53.08%
Oct 25	-54.7%
Oct 25	-54.33%
Sep 25	-53.87%
Sep 25	-55.35%
Sep 25	-56.62%
Sep 25	-48.9%
Aug 25	-16.22%
Aug 25	-14.06%
Aug 25	-13.97%
Aug 25	-15.15%
Aug 25	-19.71%
Jul 25	-18.35%
Jul 25	-16.45%
Jul 25	-17.82%
Jul 25	-17.24%
Jun 25	-18.28%
Jun 25	-18.59%
Jun 25	-17.45%
Jun 25	-16.35%
May 25	-16.45%
May 25	-291.96%
May 25	-308.43%
May 25	-317.52%
May 25	-301.78%
Apr 25	-259.31%
Apr 25	-246.52%
Apr 25	-280.05%
Apr 25	-271.89%
Mar 25	-252.3%
Mar 25	-255.99%
Mar 25	-256.93%
Mar 25	-356%
Feb 25	-335.69%
Feb 25	-315.57%
Feb 25	-322.7%
Feb 25	-333.45%
Jan 25	-307.8%
Jan 25	-273.32%
Jan 25	-282.59%
Jan 25	-257.16%
Jan 25	-221.81%
Dec 24	-229.44%
Dec 24	-292.5%
Dec 24	-261.19%
Dec 24	-213.3%
Nov 24	-298.17%
Nov 24	-586.93%
Nov 24	-513.12%
Nov 24	-457.43%
Nov 24	-413.3%
Oct 24	-313.51%
Oct 24	-294.14%

Price to Sales

PPBT Price to Sales by year
Period	Price to Sales
Aug 21	164.04
Aug 21	160.22
Aug 21	164.04
Aug 21	175.51
Jul 21	191.85
Jul 21	172.04
Jul 21	173.77
Jul 21	163.35
Jul 21	165.43
Jun 21	172.04
Jun 21	177.25
Jun 21	174.82
Jun 21	206.1
May 21	48.52
May 21	42.12
May 21	35.72
May 21	35.28
Apr 21	37.5
Apr 21	40.43
Apr 21	34.3
Apr 21	38.66
Apr 21	37.59
Mar 21	37.41
Mar 21	41.32
Mar 21	43.1
Mar 21	36.79
Feb 21	42.21
Feb 21	52.7
Feb 21	52.79
Feb 21	42.3
Jan 21	35.28
Jan 21	40.97
Jan 21	38.75
Jan 21	35.55
Dec 20	33.86
Dec 20	36.7
Dec 20	36.26
Dec 20	37.06
Dec 20	37.24
Nov 20	25.36
Nov 20	24.4
Nov 20	24.94
Nov 20	24.58
Oct 20	24.88
Oct 20	28.42
Oct 20	26.02
Oct 20	26.8
Oct 20	26.02
Sep 20	24.4
Sep 20	25.78
Sep 20	25.24
Sep 20	24.64
Aug 20	26.86
Aug 20	28.66
Aug 20	31.69
Aug 20	52.28
Jul 20	48.23
Jul 20	45.07
Jul 20	46.21
Jul 20	49.32
Jul 20	55.88
Jun 20	69.7
Jun 20	34.19
Jun 20	26.97
Jun 20	29.92
May 20	13.11
May 20	15.15
May 20	13.67
May 20	12.64
May 20	9.74
Apr 20	8.77
Apr 20	10.72
Apr 20	10.02
Apr 20	8.14
Mar 20	9.55
Mar 20	6.96
Mar 20	6.43
Mar 20	16
Feb 20	11.73
Feb 20	12.51
Feb 20	14.66
Feb 20	13.88
Jan 20	14.27
Jan 20	16.23
Jan 20	16.42
Jan 20	16.35
Jan 20	15.34
Dec 19	14.86
Dec 19	14.47
Dec 19	13.65
Dec 19	14.1
Nov 19	14.47
Nov 19	13.81
Nov 19	13.62
Nov 19	13.58
Nov 19	14.62
Oct 19	14.04
Oct 19	14.36
Oct 19	13.81
Oct 19	14.25

Price to Book

PPBT Price to Book by year
Period	Price to Book
Sep 26	1.53
Sep 26	1.56
Aug 26	1.49
Aug 26	1.4
Aug 26	1.33
Aug 26	1.27
Jul 26	1.35
Jul 26	1.38
Jul 26	1.42
Jul 26	1.51
Jul 26	1.64
Jun 26	1.63
Jun 26	1.64
Jun 26	1.53
Jun 26	2.87
May 26	2.89
May 26	2.79
May 26	3.81
May 26	5.09
May 26	5.18
Apr 26	5.6
Apr 26	6
Apr 26	5.09
Apr 26	5.07
Mar 26	4.94
Mar 26	4.91
Mar 26	5.06
Mar 26	0.66
Feb 26	0.61
Feb 26	0.69
Feb 26	0.8
Feb 26	0.84
Jan 26	0.84
Jan 26	0.92
Jan 26	0.88
Jan 26	0.96
Jan 26	0.92
Dec 25	0.98
Dec 25	0.98
Dec 25	1.04
Dec 25	1.15
Nov 25	0.71
Nov 25	0.65
Nov 25	0.61
Nov 25	0.7
Oct 25	0.67
Oct 25	0.5
Oct 25	0.52
Oct 25	0.5
Oct 25	0.51
Sep 25	0.51
Sep 25	0.5
Sep 25	0.49
Sep 25	0.56
Aug 25	1.7
Aug 25	1.96
Aug 25	1.97
Aug 25	1.82
Aug 25	1.75
Jul 25	1.88
Jul 25	2.09
Jul 25	1.93
Jul 25	2
Jun 25	1.88
Jun 25	1.85
Jun 25	1.97
Jun 25	2.11
May 25	2.09
May 25	0.15
May 25	0.14
May 25	0.14
May 25	0.14
Apr 25	0.17
Apr 25	0.18
Apr 25	0.16
Apr 25	0.16
Mar 25	0.17
Mar 25	0.17
Mar 25	0.17
Mar 25	0.17
Feb 25	0.18
Feb 25	0.19
Feb 25	0.18
Feb 25	0.18
Jan 25	0.19
Jan 25	0.22
Jan 25	0.21
Jan 25	0.23
Jan 25	0.27
Dec 24	0.26
Dec 24	0.2
Dec 24	0.23
Dec 24	0.28
Nov 24	0.2
Nov 24	0.1
Nov 24	0.12
Nov 24	0.13
Nov 24	0.15
Oct 24	0.19
Oct 24	0.2

No video analysis for this stock yet. Request one from our team.

News: PPBT

globenewswire.com · 2 Sep 2026

New U.S. Patent Allowance Strengthens Protection for CAPTN-3 Modular Platform for Next-Generation Multispecific Antibodies

REHOVOT, Israel, Sept. 02, 2026 (GLOBE NEWSWIRE) -- Purple Biotech Ltd. ("Purple Biotech" or the “Company") (NASDAQ/TASE: PPBT), a clinical-stage company developing a next-generation immunotherapy platform designed to maximize anti-cancer activity while minimizing toxicity, today announced that the U.S. Patent and Trademark Office (USPTO) has issued a Notice of Allowance for a patent application covering tri-specific antibody constructs and methods of use. The patent allowance further expands the Company's intellectual property portfolio supporting its proprietary CAPTN-3 platform for conditionally activated multispecific antibodies.

defenseworld.net · 31 Aug 2026

Financial Review: Ionis Pharmaceuticals (NASDAQ:IONS) & Purple Biotech (NASDAQ:PPBT)

Ionis Pharmaceuticals (NASDAQ: IONS - Get Free Report) and Purple Biotech (NASDAQ: PPBT - Get Free Report) are both healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their profitability, dividends, institutional ownership, risk, earnings, valuation and analyst recommendations. Earnings and Valuation This table compares Ionis Pharmaceuticals

defenseworld.net · 4 Aug 2026

Purple Biotech (PPBT) Expected to Announce Quarterly Earnings on Wednesday

Purple Biotech (NASDAQ: PPBT - Get Free Report) will likely be announcing its results before the market opens on Wednesday, August 5th. Analysts expect Purple Biotech to announce earnings of ($0.98) per share for the quarter. Purple Biotech (NASDAQ: PPBT - Get Free Report) last announced its quarterly earnings data on Saturday, May 16th. The company reported